Your browser doesn't support javascript.
loading
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient.
Siddiqui, Imran; Erreni, Marco; van Brakel, Mandy; Debets, Reno; Allavena, Paola.
Afiliación
  • Siddiqui I; Department of Immunology and Inflammation, Humanitas Clinical and Research Center, 20089 Rozzano, Milan Italy ; Ludwig Center for Cancer Research, Department of Oncology, University of Lausanne, 1066 Epalinges, Switzerland.
  • Erreni M; Department of Immunology and Inflammation, Humanitas Clinical and Research Center, 20089 Rozzano, Milan Italy.
  • van Brakel M; Laboratory of Tumor Immunology, Department Medical Oncology, Erasmus MC Cancer Institute, 3000 CA Rotterdam, The Netherlands.
  • Debets R; Laboratory of Tumor Immunology, Department Medical Oncology, Erasmus MC Cancer Institute, 3000 CA Rotterdam, The Netherlands.
  • Allavena P; Department of Immunology and Inflammation, Humanitas Clinical and Research Center, 20089 Rozzano, Milan Italy.
J Immunother Cancer ; 4: 21, 2016.
Article en En | MEDLINE | ID: mdl-27096098
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: J Immunother Cancer Año: 2016 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: J Immunother Cancer Año: 2016 Tipo del documento: Article País de afiliación: Suiza